Mehdi Yousefi is a specialist in health economic evaluation and health technology assessment (HTA). His research provides evidence to inform decision-making on technologies, including new treatments, for NICE and other UK health policy makers. His expertise includes decision modelling, systematic literature reviews, and critical appraisal, with a focus on cancer and rare disease treatments.